Puma Biotechnology Inc (NAS:PBYI)
$ 3.08 -0.07 (-2.22%) Market Cap: 151.19 Mil Enterprise Value: 140.84 Mil PE Ratio: 6.55 PB Ratio: 2.13 GF Score: 57/100

Puma Biotechnology Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 10, 2020 / 06:15PM GMT
Release Date Price: $8.85 (+5.48%)
Operator

You are live.

Evan David Seigerman;dit Suisse AG
CrÃ;Research Division - VP & Senior Equity Research Analyst

© -

Excellent. Hi there, everyone. My name is Evan Seigerman. I'm the senior biopharma analyst here at Crédit Suisse, and it's my pleasure to have Puma Biotechnologies. And from Puma, we have Alan Auerbach, and he has a lovely corporate presentation for you. I'm going to pass it off to Alan. All yours.

Alan H. Auerbach
Puma Biotechnology, Inc. - Founder, Chairman, President, CEO & Secretary

Great. Thanks, Evan.

Evan David Seigerman;dit Suisse AG
CrÃ;Research Division - VP & Senior Equity Research Analyst

© -

There we go. Looks good.

Alan H. Auerbach
Puma Biotechnology, Inc. - Founder, Chairman, President, CEO & Secretary

Great. Thank you. So thank you, Evan. First of all, just a reminder, I'm going to be making forward-looking statements. So on this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot